Published in Medicine and Law Weekly, August 3rd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at BD Biosciences.
Report 1: BD Biosciences, a segment of global medical technology company BD (Becton, Dickinson and Company), and StemCell Technologies, Inc., a Vancouver-based life sciences company, announced today the launch of BD Matrigel(tm) hESC-qualified Matrix and mTeSR(tm)1 Maintenance Medium. Together, these products offer an optimized cell culture environment for hESC research.
The development of these products arises from primary research performed by Dr....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly